Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.67 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.67 |
| ▸ | MAPT | P10636 | 3/20 | 0.67 |
| ▸ | TSHR | P16473 | 2/20 | 0.67 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.67 |
| ▸ | HPGD | P15428 | 2/20 | 0.67 |
| ▸ | METAP2 | P50579 | 1/20 | 0.61 |
| ▸ | BCAT2 | O15382 | 1/20 | 0.58 |
| ▸ | PARP1 | P09874 | 2/20 | 0.52 |
| ▸ | POLB | P06746 | 1/20 | 0.52 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.52 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.52 |
| ▸ | RECQL | P46063 | 1/20 | 0.52 |
| ▸ | BLM | P54132 | 1/20 | 0.52 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.52 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.52 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.52 |
| ▸ | GAA | P10253 | 1/20 | 0.52 |
| ▸ | CTNNB1 | P35222 | 1/20 | 0.52 |
| ▸ | SIRT1 | Q96EB6 | 1/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27700719 | 0.97 | ALDH1A1 (0.70) | ALDH1A1KDM4EMAPTTSHRHSD17B10 | |
| SCHEMBL39118 | 0.97 | ALDH1A1 (0.70) | ALDH1A1KDM4EMAPTTSHRHSD17B10 | |
| SCHEMBL4967588 | 0.97 | ALDH1A1 (0.70) | ALDH1A1KDM4EMAPTTSHRHSD17B10 | |
| Hydrochloric Acid SCHEMBL8612216 | 0.94 | ALDH1A1 (0.67) | ALDH1A1KDM4EMAPTTSHRHSD17B10 | |
| Potassium SCHEMBL30716407 | 0.94 | ALDH1A1 (0.67) | ALDH1A1KDM4EMAPTTSHRHSD17B10 | |
| SCHEMBL28458750 | 0.94 | ALDH1A1 (0.67) | ALDH1A1KDM4EMAPTTSHRHSD17B10 | |
| SCHEMBL1158413 | 0.94 | ALDH1A1 (0.67) | ALDH1A1KDM4EMAPTTSHRHSD17B10 | |
| Potassium SCHEMBL317509 | 0.94 | ALDH1A1 (0.67) | ALDH1A1KDM4EMAPTTSHRHSD17B10 | |
| SCHEMBL31285706 | 0.94 | ALDH1A1 (0.67) | ALDH1A1KDM4EMAPTTSHRHSD17B10 | |
| SCHEMBL8445150 | 0.94 | ALDH1A1 (0.67) | ALDH1A1KDM4EMAPTTSHRHSD17B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 205 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116478155-B | Preparation method of grapiprant and intermediate thereof | 洛阳惠中兽药有限公司 | 2025-06-13 | — | — | CN | claimed |
| WO-2025107394-A1 | PERFLUOROPOLYETHER-MODIFIED SILICON DIOXIDE MATERIAL AND PREPARATION METHOD THEREFOR | 中石油(上海)新材料研究院有限公司 | 2025-05-30 | — | — | WO | claimed |
| CN-120025698-A | Perfluoropolyether modified silicon dioxide material and preparation method thereof | 中石油(上海)新材料研究院有限公司 | 2025-05-23 | — | — | CN | claimed |
| CN-119390584-A | Preparation of pentazocine method for preparing octyl intermediate | 和鼎(南京)医药技术有限公司 | 2025-02-07 | — | — | CN | claimed |
| CN-117263886-A | Preparation method of 2, 5-tetrahydrofuran dimethylamine | 中科国生(杭州)科技有限公司 | 2023-12-22 | — | — | CN | claimed |
| CN-116478155-A | Preparation method of grapiprant and intermediate thereof | 洛阳惠中兽药有限公司 | 2023-07-25 | — | — | CN | claimed |
| CN-114230628-A | Quinacridone cholesterol compound and preparation method and application thereof | 华东理工大学 | 2022-03-25 | — | — | CN | claimed |
| CN-109438351-B | Preparation method of pentazocine intermediate | 和鼎(南京)医药技术有限公司 | 2021-04-23 | — | — | CN | claimed |
| CN-108373419-B | 3-branched alkyl chain and preparation method thereof | 九江德思光电材料有限公司 | 2020-12-22 | — | — | CN | claimed |
| WO-2015162622-A1 | PROCESS FOR PREPARATION OF LINEZOLID | VIRDEV INTERMEDIATES PVT. LTD. (IN) | 2015-10-29 | — | — | WO | claimed |
| US-20040006238-A1 | Process to produce oxazolidinones | PHARMACIA & UPJOHN COMPANY | 2004-01-08 | — | — | US | claimed |
| US-20030216572-A1 | PROCESS TO PRODUCE OXAZOLIDINONES | PHARMACIA & UPJOHN COMPANY | 2003-11-20 | — | — | US | claimed |
| US-20030130509-A1 | PROCESS TO PRODUCE 3-CARBON AMINO ALCOHOL SALTS | PHARMACIA & UPJOHN COMPANY | 2003-07-10 | — | — | US | claimed |
| US-20030065219-A1 | PROCESS TO PRODUCE OXAZOLIDINONES | PHARMACIA & UPJOHN COMPANY | 2003-04-03 | — | — | US | claimed |
| US-20020095054-A1 | Process to produce oxazolidinones | PHARMACIA & UPJOHN COMPANY | 2002-07-18 | — | — | US | claimed |
| US-20020032348-A1 | Process to produce oxazolidinones | PEARLMAN BRUCE ALLEN (US) | 2002-03-14 | — | — | US | claimed |
| EP-1028940-A1 | PROCESS TO PRODUCE OXAZOLIDINONES | PHARMACIA & UPJOHN COMPANY (US) | 2000-08-23 | — | — | EP | claimed |
| WO-1999024393-A1 | PROCESS TO PRODUCE OXAZOLIDINONES | PHARMACIA & UPJOHN COMPANY (US) | 1999-05-20 | — | — | WO | claimed |
| CN-1030415-A | Saturated heterocycle carboxamide derivatives and its preparation method | YAMANOUCHI PHARMA CO LTD (JP) | 1989-01-18 | — | — | CN | claimed |
| EP-0279681-A2 | Saturated heterocyclic carboxamide derivatives | YAMANOUCHI PHARMACEUTICAL CO. LTD. (JP) | 1988-08-24 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030065219-A1 | PROCESS TO PRODUCE OXAZOLIDINONES | ADH1A, ADH5, ADH1C | ALDH1A1 109/4885KDM4E 2057/4885MAPT 3538/4885 |
| US-20030130509-A1 | PROCESS TO PRODUCE 3-CARBON AMINO ALCOHOL SALTS | ADH1A, ADH5, ADH1C | ALDH1A1 73/4885KDM4E 2039/4885MAPT 3318/4885 |
| US-20040006238-A1 | Process to produce oxazolidinones | ADH1A, ADH5, ADH1C | ALDH1A1 142/4885KDM4E 2156/4885MAPT 3496/4885 |
| US-20020095054-A1 | Process to produce oxazolidinones | ADH1A, ADH5, ADH1C | ALDH1A1 109/4885KDM4E 2057/4885MAPT 3538/4885 |
| US-20030216572-A1 | PROCESS TO PRODUCE OXAZOLIDINONES | ADH1A, ADH5, ADH1C | ALDH1A1 109/4885KDM4E 2057/4885MAPT 3538/4885 |
| US-20020032348-A1 | Process to produce oxazolidinones | ADH1A, ADH5, ADH1C | ALDH1A1 109/4885KDM4E 2057/4885MAPT 3538/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.